Disc Medicine received a Complete Response Letter (CRL) from FDA for its New Drug Application (NDA) for bitopertin as a treatment for erythropoietic protoporphyria (EPP), delaying a potential ...
New research has shown that the production of heme, a blood molecule, supports the progression of acute myeloid leukemia, which is an aggressive form of blood cancer. Researchers say that suppressing ...